等待开盘 11-18 09:30:00 美东时间
-1.155
-1.81%
11月17日,Eton Pharmaceuticals(ETON)收跌0.08%,报63.88美元,成交额3873.59万美元,市值18.42亿美元。 行情数据...
11-17 06:26
B. Riley Securities analyst Madison El-Saadi maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $70 to $81.
11-11 01:45
今日重点评级关注:瑞银:维持Liberty Media"中性"评级,目标价从110美元升至1116美元;杰富瑞:维持伊诺维奥制药"买入"评级,目标价从3美元升至8美元
11-09 14:00
最新财报显示,Eton Pharmaceuticals 2026财年第3季度实现: 营业收入:5792.5万美元 同比:增长157.91% 每股收益:1.23美...
11-07 11:00
11月7日,Eton Pharmaceuticals(ETON)收涨19.75%,报56.46美元,成交额7065.71万美元,市值16.14亿美元。 行情数据...
11-07 06:30
Eton Pharmaceuticals has launched ET-900, a new program evaluating mecasermin (IGF-1) for treating infantile and epileptic spasms. The company licensed patent rights from Baylor College of Medicine for IGF-1 use in spasms. Preclinical research showed IGF-1 therapy reduced spasms in animals. An IND application for a Phase 2 study in children with refractory epileptic spasms has been submitted to the FDA, with dosing planned for Q1 2027. Eton retai...
11-02 11:50
10月31日,Eton Pharmaceuticals(ETON)收跌2.78%,报52.18美元,成交额1752.97万美元,市值14.91亿美元。 行情数据...
10-31 05:34
Eton Pharmaceuticals, Inc. will report third quarter 2026 financial results on November 5, 2026. Management will host a conference call and live audio webcast at 4:30 p.m. ET, with links provided for participants and webcast access. Investors can submit questions via email to investorrelations@etonpharma.com. An archived webcast will be available on Eton’s website for 30 days. Eton focuses on developing treatments for rare diseases, with twelve a...
10-29 10:50
10月23日,Eton Pharmaceuticals(ETON)收涨1.46%,报50.02美元,成交额2396.05万美元,市值14.3亿美元。 行情数据...
10-23 05:37
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:37